A recorded live event where a team of top oncologists discusses emerging concepts and best practices in non-small cell lung cancer (NSCLC).

In this video, Dr. Millie Das discusses utilizing neoadjuvant nivolumab plus chemo in patients with stage 1B-3A NSCLC and no EGFR or ALK alterations, and the trial's implications for treatment.

For more, please visit [ Ссылка ]. To join the conversation, visit [ Ссылка ].

Music: Memories (BenSound)
License: ILNGCTH0PLMCVBDH

свернуть